BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeeshan M, Ali H, Khan S, Mukhtar M, Khan MI, Arshad M. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Nanomedicine 2019;14:1945-69. [DOI: 10.2217/nnm-2018-0415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lechner K, Zeeshana M, Noack M, Ali H, Neurath M, Weigmanna B. Small but powerful: Will nanoparticles be the future state‐of‐the‐art therapy for IBD? Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2043847] [Reference Citation Analysis]
2 Yang C, Merlin D. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. Int J Nanomedicine 2019;14:8875-89. [PMID: 32009785 DOI: 10.2147/IJN.S210315] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
3 Mukhtar M, Zesshan M, Khan S, Shahnaz G, Khan SA, Sarwar HS, Pasha RA, Ali H. Fabrication and optimization of pH-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake. Appl Nanosci 2020;10:4013-27. [DOI: 10.1007/s13204-020-01510-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang CJ, Byun MJ, Kim S, Park W, Park HH, Kim T, Lee JS, Park CG. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.028] [Reference Citation Analysis]
5 Shen C, Zhu J, Song J, Wang J, Shen B, Yuan H, Li X. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid. Drug Development and Industrial Pharmacy 2020;46:1100-7. [DOI: 10.1080/03639045.2020.1775634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Minakshi P, Kumar R, Ghosh M, Brar B, Barnela M, Lakhani P. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Curr Top Med Chem 2020;20:982-1008. [PMID: 32196449 DOI: 10.2174/1568026620666200320113322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sun Z, He G, Huang N, Thilakavathy K, Lim JCW, Kumar SS, Xiong C. Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19. Front Pharmacol 2021;12:707205. [PMID: 34305613 DOI: 10.3389/fphar.2021.707205] [Reference Citation Analysis]
9 Zeeshan M, Ali H, Ain QU, Mukhtar M, Gul R, Sarwar A, Khan S. A holistic QBD approach to design galactose conjugated PLGA polymer and nanoparticles to catch macrophages during intestinal inflammation. Mater Sci Eng C Mater Biol Appl 2021;126:112183. [PMID: 34082983 DOI: 10.1016/j.msec.2021.112183] [Reference Citation Analysis]
10 Nedelcu A, Mosteanu O, Pop T, Mocan T, Mocan L. Recent Advances in Nanoparticle-Mediated Treatment of Inflammatory Bowel Diseases. Applied Sciences 2021;11:438. [DOI: 10.3390/app11010438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shao F, Zhang M, Xu L, Yin D, Li M, Jiang Q, Zhang Q, Yang Y. Multiboosting of Cancer Immunotherapy by a Core-Shell Delivery System. Mol Pharm 2020;17:338-48. [PMID: 31793786 DOI: 10.1021/acs.molpharmaceut.9b01113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
12 Sana E, Zeeshan M, Ain QU, Khan AU, Hussain I, Khan S, Lepeltier E, Ali H. Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-κβ pathway. Nanomedicine (Lond) 2021;16:819-37. [PMID: 33900118 DOI: 10.2217/nnm-2020-0316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mukhtar M, Pallagi E, Csóka I, Benke E, Farkas Á, Zeeshan M, Burián K, Kókai D, Ambrus R. Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment. International Journal of Biological Macromolecules 2020;165:3007-19. [DOI: 10.1016/j.ijbiomac.2020.10.192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Jacob EM, Borah A, Pillai SC, Kumar DS. Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease. Polymers (Basel) 2021;13:862. [PMID: 33799680 DOI: 10.3390/polym13060862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]